By Admin at 4 Apr 2016
Osteosarcoma is a rare form of primary bone cancer that typically affects children and young adults. New research published in The Journal of Pathology revealed a novel treatment that may protect bones and reduce amputations in people with osteosarcoma.
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial
